Drug profile · INN
tivozanib
TIVOZANIB
tivozanib (TIVOZANIB) is a vascular endothelial growth factor receptor inhibitor. Current US regulatory status: approved.
Drug details — tivozanib
- US status
- approved
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.81
Quick answer
tivozanib (TIVOZANIB) is a vascular endothelial growth factor receptor inhibitor. Current US regulatory status: approved.
Key facts
Mechanism of action
Vascular endothelial growth factor receptor inhibitor
Primary target: Vascular endothelial growth factor receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is tivozanib?
tivozanib (TIVOZANIB) is a vascular endothelial growth factor receptor inhibitor. Current US regulatory status: approved.
What is the brand name for tivozanib?
TIVOZANIB is a marketed brand name for tivozanib. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tivozanib?
tivozanib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.